Cargando…

Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer

The biological properties of circulating tumor cells (CTCs), and their dynamics during neoadjuvant chemotherapy are important, both for disease progression prediction and therapeutic target determination, with the aim of preventing disease progression. The aim of our study was to estimate of differe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaigorodova, Evgeniya V., Savelieva, Olga E., Tashireva, Liubov A., Tarabanovskaya, Natalia A., Simolina, Elena I., Denisov, Evgeny V., Slonimskaya, Elena M., Choynzonov, Evgeny L., Perelmuter, Vladimir M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017975/ https://www.ncbi.nlm.nih.gov/pubmed/29565320 http://dx.doi.org/10.3390/molecules23040727

Ejemplares similares

Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment
por: Perelmuter, Vladimir M, et al.
Publicado: (2019)

Heterogeneity of Stemlike Circulating Tumor Cells in Invasive Breast Cancer
por: Savelieva, Olga E., et al.
Publicado: (2020)

Single Tumor Cells With Epithelial-Like Morphology Are Associated With Breast Cancer Metastasis
por: Tashireva, Liubov A., et al.
Publicado: (2020)

Heterogeneous Manifestations of Epithelial–Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients
por: Tashireva, Liubov A., et al.
Publicado: (2021)

Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression
por: Denisov, Evgeny V., et al.
Publicado: (2014)

Neoadjuvant chemotherapy combined with intraoperative radiotherapy is effective to prevent recurrence in high-risk non-small cell lung cancer (NSCLC) patients
por: Pankova, Olga V., et al.
Publicado: (2020)

The Novel Association of Early Apoptotic Circulating Tumor Cells with Treatment Outcomes in Breast Cancer Patients
por: Grigoryeva, Evgeniya S., et al.
Publicado: (2022)

Phenotypic Drift as a Cause for Intratumoral Morphological Heterogeneity of Invasive Ductal Breast Carcinoma Not Otherwise Specified
por: Zavyalova, Marina V., et al.
Publicado: (2013)

The Association of Integrins β3, β4, and αVβ5 on Exosomes, CTCs and Tumor Cells with Localization of Distant Metastasis in Breast Cancer Patients
por: Grigoryeva, Evgeniya S., et al.
Publicado: (2023)

Premalignant Changes in the Bronchial Epithelium Are Prognostic Factors of Distant Metastasis in Non-Small Cell Lung Cancer Patients
por: Pankova, Olga V., et al.
Publicado: (2021)

The Activity of KIF14, Mieap, and EZR in a New Type of the Invasive Component, Torpedo-Like Structures, Predetermines the Metastatic Potential of Breast Cancer
por: Gerashchenko, Tatiana S., et al.
Publicado: (2020)

Spatial Profile of Tumor Microenvironment in PD-L1-Negative and PD-L1-Positive Triple-Negative Breast Cancer
por: Tashireva, Liubov A., et al.
Publicado: (2023)

LIMCH1 as a New Potential Metastasis Predictor in Breast Cancer
por: Alifanov, Vladimir Valerievich, et al.
Publicado: (2022)

B Lymphocytes Are a Predictive Marker of Eribulin Response and Overall Survival in Locally Advanced or Metastatic Breast Cancer: A Multicenter, Two-Cohort, Non-Randomized, Open-Label, Retrospective Study
por: Tashireva, Liubov A., et al.
Publicado: (2022)

Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds
por: Menyailo, Maxim E., et al.
Publicado: (2020)

Hybrid/Atypical Forms of Circulating Tumor Cells: Current State of the Art
por: Kaigorodova, Evgeniya V., et al.
Publicado: (2022)

Amplifications of stemness genes and the capacity of breast tumors for metastasis
por: Litviakov, Nikolai, et al.
Publicado: (2020)

Clinically relevant morphological structures in breast cancer represent transcriptionally distinct tumor cell populations with varied degrees of epithelial-mesenchymal transition and CD44(+)CD24(-) stemness
por: Denisov, Evgeny V., et al.
Publicado: (2017)

Amplifications of Stemness Gene Loci—New Markers for the Determination of the Need for Neoadjuvant Chemotherapy for Patients with Breast Cancer. A Prospective Study
por: Litviakov, Nikolai V., et al.
Publicado: (2021)

Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy
por: Litviakov, Nikolai V., et al.
Publicado: (2016)

DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer
por: Sigin, Vladimir O., et al.
Publicado: (2020)

Cortical branched actin determines cell cycle progression
por: Molinie, Nicolas, et al.
Publicado: (2019)

Molecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancer
por: Grigoryeva, E. S., et al.
Publicado: (2022)

Effect of Targeted Therapy With Pazopanib on Expression Levels of Transcription, Growth Factors and Components of AKT/m-TOR Signaling Pathway in Patients with Renal Cell Carcinoma
por: Spirina, Liudmila V, et al.
Publicado: (2017)

DNA Copy Number Aberrations and Expression of ABC Transporter Genes in Breast Tumour: Correlation with the Effect of Neoadjuvant Chemotherapy and Prognosis of the Disease
por: Tsyganov, Matvey M., et al.
Publicado: (2022)

Markers of Cancer Cell Invasion: Are They Good Enough?
por: Gerashchenko, Tatiana S., et al.
Publicado: (2019)

Determination of BRCAness Phenotype in Breast Tumors for the Appointment of Neoadjuvant Chemotherapy Based on Platinum and Taxanes
por: Tsyganov, Matvey Mihajlovich, et al.
Publicado: (2022)

Immune gene signatures as prognostic criteria for cancer patients
por: Larionova, Irina, et al.
Publicado: (2023)

Regulation of Immunity in Clear Cell Renal Carcinoma: Role of PD-1, PD-L1, and PD-L2
por: Spirina, Liudmila, et al.
Publicado: (2021)

Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy——AKT/m-TOR Pathway and Resistance to Cancer Therapy
por: SPIRINA, Liudmila V, et al.
Publicado: (2018)

Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy
por: Liu, Tengfei, et al.
Publicado: (2018)

Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity
por: Gerashchenko, T.S., et al.
Publicado: (2017)

Characterization of circulating tumor cells in early breast cancer patients receiving neoadjuvant chemotherapy
por: Jakabova, Anna, et al.
Publicado: (2021)

Technologies for Viable Circulating Tumor Cell Isolation
por: Tretyakova, Maria S., et al.
Publicado: (2022)

Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy
por: Sánchez-Margalet, Víctor, et al.
Publicado: (2019)

Analysis of Circulating Tumor and Cancer Stem Cells Provides New Opportunities in Diagnosis and Treatment of Small Cell Lung Cancer
por: Skurikhin, Evgenii G., et al.
Publicado: (2022)

Molecular Recognition of Imidazole Derivatives by Co(III)-Porphyrins in Phosphate Buffer (pH = 7.4) and Cetylpyridinium Chloride Containing Solutions
por: Mamardashvili, Galina, et al.
Publicado: (2021)

Peripheral sensory neurons govern development of the nervous system in bivalve larvae
por: Yurchenko, Olga V., et al.
Publicado: (2019)

Phase I Trial of (99m)Tc-(HE)(3)-G3, a DARPin-Based Probe for Imaging of HER2 Expression in Breast Cancer
por: Bragina, Olga, et al.
Publicado: (2022)

Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model
por: Xu, Tianqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c7d25nsmev8qa81m5dc4be34jk